In view of including the data of the study "Clinical evidence of efficacy of red yeast rice and berberine in a large controlled study versus diet" by Trimarco B, Benvenuti C, et al. Mediterr J Nutr Metab (2011) 4:13-19, in an international based meta-analysis, it was judged appropriate, for reason of total transparency, to add more information concerning the methods that were applied. These amendments to the paper, are based on the operative procedure contained in the official protocol "Controlled clinical study on Armolipid Plus, food supplement active on cholesterol and triglycerides in CV risk and metabolic syndrome control".
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C. Benvenuti / Methodological details on a published study on red yeast rice and berberine
The management of the study encouraged more the participation of the doctors and the subjects, in order to collect as many clinical data and privileged the primary end point (total cholesterol at 8 weeks and adverse events reporting).
The analysis of the data was performed using all the data available, as making calculation on a larger basis avoided losing information or discarding useful data and increased the knowledge on the product. Consequently, the data available at each time for each parameter, were compared with the paired baseline values, and the statistical analysis was conducted time by time between the calculate differences of the groups of treatment.
In conclusion, the study produced robust data, because it was carried out in conditions better resembling the usual daily clinical practice, without a rigorous selection of participating centres, and with simple enrolment criteria, i.e. abnormal cholesterol values and no need or unfeasibility to give a prescription drug.
The laboratory analyses for lipid determination were performed by the individual laboratories of usual reference for the doctors involved that routinely base their prescriptions on these lab values. For this reason and for the planned lack of diet standardisation, the outcomes of the study can be more widely extrapolated.
